Autoimmune hepatitis: "Hepatitis sui generis"

Journal of Hepatology

Volumn 38, Issue 2, 2003, Pages 130-135

  Meyer Zum Büschenfelde, Karl Hermann ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CLINICAL FEATURE; LIVER CIRRHOSIS; LIVER FAILURE; NOTE; PRIORITY JOURNAL;

EID: 0037310110     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00408-7     Document Type: Note

References (64)

1. Waldenström J Leber. Blutproteine und Nahrungseiweiss. Deutsch Z Verdau Stoffwechselk 1950;15:113-119.
2. Amberg S, Hyperproteinaemia associated with severe liver damage. Proc Staff Meet May Clin 1942;17:360-362.
3. Wood IJ, King WE, Parson PJ, Perry JW, Freeman M, Limbrick L. Non-suppurative hepatitis: a study of acute and chronic forms with special reference to biochemical and histological changes. Med J Aust 1948;11:249-261.
4. Kalk H. Die chronische Verlaufsform der Hepatitis epidemica in ihrer Beziehung zu ihrer anatomischen Grundlage. Dtsch Med Wochenschr 1947:308-314.
5. Capps RB. Clinical aspects of the sequelae of acute hepatitis. Gastroenterology 1948;11:680-684.
6. De Groote J, Desmer VJ, Gedigk P, Korb GH, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet 1968;ii:626-628.
7. Meyer zum Büschenfelde KH, Lohse AW, Manns M, Poralla T. Autoimmunity and liver disease. Hepatology 1990;12:354-363.
8. Kunkel HG, Ahrens JR, Eisenmenger WJ, Bougiovanni AM, Slater RJ. Extreme hypergammaglobulinemia in young women with liver disease of unknown etiology. J Clin Invest 1951;30:654 (abstract).
9. Bearn AG, Kunkel HG, Slater RJ. The problem of chronic liver disease in young women. Am J Med 1956;21:3-15.
10. Joske RA, King WE. The LE cell phenomenon in active chronic viral hepatitis. Lancet 1955;ii:477-480.
11. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956;ii:1323-1326.
12. Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sci 1965;124:767-780.
13. Johnson PJ, McFarlane IG. Meeting Report: International autoimmune hepatitis group. Hepatology 1993;18:998-1005.
14. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
15. Holborow EJ, Asherson GL, Johnson GD, Barnes RDS, Carmichael PS. Antinuclear factor and other antibodies in blood and liver diseases. Br Med J 1963;i:656-658.
16. Johnson GD, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet 1965;ii:878-879.
17. Wittingham S, Mackay IR, Irwin J. Autoimmune hepatitis: immuno-fluorescence reactions with cytoplasm of smooth muscle and glomerular cells. Lancet 1966:i:1333-1335.
18. Gurian LE, Rogoff TM, Ware AJ, Gordon RE, Coombes B, Gilliam JN. The immunologic diagnosis of chronic active 'autoimmune' hepatitis: distinction from systemic lupus erythematosus. Hepatology 1985;5:397-402.
19. Mackay IR. The hepatitis lupus connection. Semin Liver Dis 1991;11:234-240.
20. Zimmermann HJ, Heller P, Hill RP. Extreme hyperglobulinemia in subacute hepatic necrosis. N Engl J Med 1951;244:245-249.
21. Gajdusek DC. An 'autoimmune' reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations. Arch Intern Med 1958:101:9-29.
22. Mackay IR, Gajdusek DC. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. II. Clinical correlations. Arch Intern Med 1958;101:30-46.
23. Meyer zum Büschenfelde KH. Schrank CH. Untersuchungen zur Frage organspezifischer Antigene der Leber. Kiln Wochenschr 1966;44:654-656.
24. Meyer zum Büschenfelde KH. Immunpathogenese chronisch entzündlicher Lebererkrankungen. Ergebnisse Innere Med u Kinderheilkunde 1972;32:31-81.
25. Meyer zum Büschenfelde KH, Miescher PA. Liver-specific antigens, purification and characterization. Clin Exp Immunol 1972;10:89-102.
26. Meyer zum Büschenfelde KH, Knolle J, Berger J. Celluläre Immunreaktionen gegenüber homologen leberspecifischen Antigenen (HLP) bei chronischen Leberentzündungen. Klin Wochenschr 1974;52:246-248.
27. Hopf U, Meyer zum Büschenfelde KH, Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 1976;294:578-582.
28. Lohse AW. Experimental hepatitis. In: Cohen IR, Miller A. editors. Autoimmune disease models: a guidebook, San Diego: Academic Press. 1994. pp. 191-199.
29. Sherlock S, Dooley J. Disease of the liver and biliary system. 9th ed., Oxford, UK: Blackwell, 1993.
30. Parker DR, Kingham JGC, Type I, autoimmune hepatitis is primarily a disease of later life. Q I Med 1997;90:289-296.
31. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 1997;26:1207-1212.
32. Selby CD, Toghill PJ. Chronic active hepatitis in the elderly. Age Ageing 1986;15:350-356.
33. Schramm CH, Kanzler St, Meyer zum Büschenfelde KH. Galle PR. Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001;96:1587-1591.
34. Blumberg DS. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Am Intern Med 1967;66:924-931.
35. Feinstone SM, Daemer RJ, Purcell RM. Hepatitis A: detection by immune electron microscopy of a virus-like particle associated with acute illness. Science 1973;182:1026-1028.
36. Rizetto M, Canese MG, Arico S, Crivelli O, Bonino F, Trepo CG, et al. Immunofluorescence detection of a new antigen-antibody system (delta/anti delta) associated to hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977;18:997-1003.
37. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from the blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
38. McFarlane IG. Autoimmunity and hepatotropic viruses. Semin Liver Dis 1991;11:223-233.
39. McFarlane BM, Bridger C, Tibbs CJ, McFarlane IG. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J Med Virol 1994;42:66-72.
40. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 1993;18:342-352.
41. Lohse AW, Gerken G, Mohr H, Löhr HF, Treichel U, Dienes HP, et al. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z Gastroenterol 1995;33:527-533.
42. Johnson PJ, McFarlane IG, Eddleston ALWF. The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 1991;11:187-196.
43. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334:897-903.
44. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588-598.
45. Leggett BA. Hallam A. Powell EE. Powell LW. Autoimmune chronic active hepatitis evolving to primary sclerosing cholangitis: evidence for a common pathogenesis [abstract]. Hepatology 1992;16:191A.
46. Lawrence SP, Shermann KE, Lawson JM, Goodman ZD. A 39 year old man with chronic hepatitis. Semin Liver Dis 1994;14:97-105.
47. Gohlke F, Lohse AW, Dienes HP. Löhr H, Märker-Herrmann E, Gerken G, et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996;24:699-705.
48. Wurbs D, Klein R, Terracciano LM, Berg PA, Bianchi L. A 28-year-old woman with a combined hepatitis cholestatic syndrome. Hepatology 1995;22:1598-1605.
49. Lohse AW, Meyer zum Büschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999;29:1078-1084.
50. Manns M. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance. Semin Liver Dis 1991;11:205-214.
51. Jensen DM, McFarlane IG, Portmann B, Eddleston ALWF, Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic hepatitis. N Engl J Med 1978;299:1-7.
52. Treichel U, Poralla T, Hess G. Manns M, Meyer zum Büschenfelde KH. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 1990;11:606-612.
53. Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterol 1994;107:799-804.
54. Wies I, Brunner S, Henninger J, Herkel J, Meyer zum Büschenfelde KH, Lohse AW. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000;355:1510-1515.
55. Herkel J, Heidrich B, Nieraad N, Wies I, Rother M, Lohse AW. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Hepatology 2002;35:403-408.
56. Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler St, Cancado ELR, et al. Establishment of standardized SLA/LP immunoassays, specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002;50:0-5.
57. Meyer zum Büschenfelde KH, Gerken G. Immune mechanisms in the production of liver diseases. In: Zakim D, Boyer Th. editors. Hepatology - a textbook of liver diseases, IV ed., London: W.B. Saunders, 2002 (Chapter 37).
58. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PH, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701-706.
59. Donaldson PT, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver diseases. Hepatology 1994;20:225-239.
60. Seki T, Kiyosawa K, Ota M. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology 1990;12:1300-1304.
61. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S. Late results of the Royal Free Hospital prospective controlled trial in hepatitis B surface antigen negative chronic active hepatitis. Gut 1980;21:78-83.
62. Maddrey WC, Combes B. Therapeutic concepts for the management of idiopathic autoimmune chronic hepatitis. Semin Liver Dis. 1991;11:248-255.
63. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-963.
64. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-547.